Benefits and harms of osteoporosis medications unclear for patients with CKD
1. While osteoporosis medications may have some benefits in chronic kidney disease patients (CKD), the evidence is unclear with respect ...
1. While osteoporosis medications may have some benefits in chronic kidney disease patients (CKD), the evidence is unclear with respect ...
1. Metformin use is associated with reduced all-cause mortality in patients with chronic kidney disease, congestive heart failure, or chronic ...
1. This study quantified sodium intake by measuring the 24-hour urinary sodium excretion, and found that among patients with chronic ...
1. From this systematic review and meta-analysis, use of erythropoietin-stimulating agents (ESAs) to achieve high hemoglobin targets in patients with ...
1. Amongst two prospective cohorts, use of proton pump inhibitors (PPIs) was associated with a 20 – 50% higher ...
1. Depletion of dynamin, a protein involved in maintenance of the actin cytoskeleton, resulted in decreased circulation of large proteins ...
1. From a systematic review, elevated troponin levels were associated with increased all-cause mortality and adverse cardiovascular events among those ...
1. Among patients with chronic kidney disease, a goal systolic blood pressure between 120-139 mmHg was associated with a lower ...
Image: PD 1. Irbesartan was associated with a significantly lower risk of doubling of serum creatinine concentration, developing end-stage renal ...
Image: PD 1. Among US veterans with non-dialysis dependent chronic kidney disease, diastolic blood pressure lower than 70 mm Hg ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.